United States · FDA National Drug Code directory

Liothyronine Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0093-2180_5a80850c-0302-4dc1-a1e3-06d21dec53aa
Product NDC: 0093-2180
Form: TABLET
Composition / generic term: Liothyronine Sodium
Labeler: Teva Pharmaceuticals USA, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20210226
Source listing expiry: 20271231

Source-listed ingredients

LIOTHYRONINE SODIUM — 50 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (0093-2180-01) · 0093-2180-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →